vs

Side-by-side financial comparison of Karooooo Ltd. (KARO) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $58.4M, roughly 1.4× Karooooo Ltd.). Karooooo Ltd. runs the higher net margin — 20.8% vs -38.1%, a 58.9% gap on every dollar of revenue.

Karooooo Ltd is a global mobility telematics provider operating primarily under its Cartrack brand. It delivers connected vehicle solutions, fleet management services, stolen vehicle recovery support, and driver safety tools, serving both individual consumers and enterprise clients across Africa, Europe, and the Asia Pacific region.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

KARO vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.4× larger
PRCT
$83.1M
$58.4M
KARO
Higher net margin
KARO
KARO
58.9% more per $
KARO
20.8%
-38.1%
PRCT

Income Statement — Q1 FY2025 vs Q1 FY2026

Metric
KARO
KARO
PRCT
PRCT
Revenue
$58.4M
$83.1M
Net Profit
$12.2M
$-31.6M
Gross Margin
69.1%
64.9%
Operating Margin
27.7%
-4.1%
Net Margin
20.8%
-38.1%
Revenue YoY
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KARO
KARO
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$76.4M
Q3 25
$83.3M
Q2 25
$79.2M
Q1 25
$69.2M
Q4 24
$68.2M
Q3 24
$58.4M
Q2 24
$58.4M
$53.4M
Net Profit
KARO
KARO
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$-21.4M
Q2 25
$-19.6M
Q1 25
$-24.7M
Q4 24
$-18.9M
Q3 24
$-21.0M
Q2 24
$12.2M
$-25.6M
Gross Margin
KARO
KARO
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
69.1%
59.0%
Operating Margin
KARO
KARO
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-40.6%
Q3 25
-27.8%
Q2 25
-28.0%
Q1 25
-39.7%
Q4 24
-28.9%
Q3 24
-38.4%
Q2 24
27.7%
-50.3%
Net Margin
KARO
KARO
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
-25.7%
Q2 25
-24.7%
Q1 25
-35.8%
Q4 24
-27.6%
Q3 24
-35.9%
Q2 24
20.8%
-48.0%
EPS (diluted)
KARO
KARO
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$-0.38
Q2 25
$-0.35
Q1 25
$-0.45
Q4 24
$-0.34
Q3 24
$-0.40
Q2 24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KARO
KARO
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$53.8M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$170.4M
$347.7M
Total Assets
$246.5M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KARO
KARO
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$53.8M
$214.1M
Total Debt
KARO
KARO
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
KARO
KARO
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$365.9M
Q3 25
$380.3M
Q2 25
$385.8M
Q1 25
$389.2M
Q4 24
$402.2M
Q3 24
$241.2M
Q2 24
$170.4M
$251.8M
Total Assets
KARO
KARO
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$508.1M
Q3 25
$511.5M
Q2 25
$513.1M
Q1 25
$519.4M
Q4 24
$534.0M
Q3 24
$374.1M
Q2 24
$246.5M
$374.4M
Debt / Equity
KARO
KARO
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KARO
KARO
PRCT
PRCT
Operating Cash FlowLast quarter
$45.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.71×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KARO
KARO
PRCT
PRCT
Q1 26
Q4 25
$-10.3M
Q3 25
$-6.6M
Q2 25
$-15.0M
Q1 25
$-17.0M
Q4 24
$-32.4M
Q3 24
$-18.8M
Q2 24
$45.2M
$-15.7M
Free Cash Flow
KARO
KARO
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
KARO
KARO
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
KARO
KARO
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
KARO
KARO
PRCT
PRCT
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
3.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KARO
KARO

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons